Literature DB >> 8586819

Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels.

M Hausberg1, A L Mark, R P Hoffman, C A Sinkey, E A Anderson.   

Abstract

OBJECTIVE: To determine sympathetic and vascular responses to modest increases in plasma insulin level.
BACKGROUND: Most studies of sympathetic and vascular actions of insulin have evaluated high plasma insulin levels ( > 50 microU/ml). Those levels increase sympathetic nerve activity but also cause vasodilation. Hypertension and obesity are associated with only modestly elevated fasting insulin levels.
METHODS: We investigated the effects of a 90 min low-dose hyperinsulinemic euglycemic clamp on muscle sympathetic nerve activity (microneurography), forearm vascular resistance (plethysmography), heart rate, blood pressure and central venous pressure. Insulin and vehicle sessions were performed in 12 normal subjects.
RESULTS: Plasma insulin levels were elevated from values of 10 +/- 2 in the fasting state to 25 +/- 3 microU/ml during insulin infusion. Insulin levels did not change during vehicle administration. Muscle sympathetic nerve activity increased from 16 +/- 2 to 25 +/- 3 burst/min during the insulin session and did not change during vehicle administration. In contrast to muscle sympathetic nerve activity, forearm vascular resistance did not change during insulin administration (from 50 +/- 3 to 51 +/- 4 U). Forearm vascular resistance tended to fall during vehicle administration (from 45 +/- 2 to 37 +/- 3 U). There were no changes in heart rate, blood pressure and central venous pressure that could be attributed to insulin.
CONCLUSIONS: Modest elevations of plasma insulin levels produce sympathetic activation similar to that caused by high levels, but, in contrast to high levels modest elevations in plasma insulin level do not decrease forearm vascular resistance. The present findings suggest a dissociation between sympathoexcitatory and vascular actions of insulin at low plasma levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586819     DOI: 10.1097/00004872-199509000-00012

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  18 in total

Review 1.  Obesity and adipokines: effects on sympathetic overactivity.

Authors:  Michael M Smith; Christopher T Minson
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

2.  Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans.

Authors:  Colin N Young; Shekhar H Deo; Kunal Chaudhary; John P Thyfault; Paul J Fadel
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

3.  Insulin resistance and the metabolic syndrome.

Authors:  L Landsberg
Journal:  Diabetologia       Date:  2005-07       Impact factor: 10.122

4.  Sustained hyperglycaemia increases muscle blood flow but does not affect sympathetic activity in resting humans.

Authors:  P J van Gurp; G A Rongen; J W M Lenders; A K M Al Nabawy; H J L M Timmers; C J Tack
Journal:  Eur J Appl Physiol       Date:  2004-11-25       Impact factor: 3.078

Review 5.  Feast or famine: the sympathetic nervous system response to nutrient intake.

Authors:  Lewis Landsberg
Journal:  Cell Mol Neurobiol       Date:  2006-05-17       Impact factor: 5.046

Review 6.  The organization of the stress system and its dysregulation in depressive illness.

Authors:  P W Gold
Journal:  Mol Psychiatry       Date:  2014-12-09       Impact factor: 15.992

Review 7.  Central sympathetic overactivity: maladies and mechanisms.

Authors:  James P Fisher; Colin N Young; Paul J Fadel
Journal:  Auton Neurosci       Date:  2009-03-06       Impact factor: 3.145

8.  Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans.

Authors:  Adil E Bharucha; Nisha Charkoudian; Christopher N Andrews; Michael Camilleri; David Sletten; Alan R Zinsmeister; Phillip A Low
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-02       Impact factor: 3.619

Review 9.  The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.

Authors:  Massimo Leggio; Mario Lombardi; Elisa Caldarone; Paolo Severi; Stefania D'Emidio; Massimo Armeni; Veronica Bravi; Maria Grazia Bendini; Andrea Mazza
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

Review 10.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.